Mai Yagi
Kamakura, 2488555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Corrigendum to "Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives" [Bioorg Med Chem Lett 27(16) (2017) 3920-3924].
Journal: Bioorganic & medicinal chemistry letters
Published: December 24, 2018
Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: May 08, 2017
Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
Journal: Leukemia & lymphoma
Published: September 22, 2015
Discovery of potent α1L-adrenoceptor agonists: Design and synthesis of bicyclic derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: January 15, 2015
Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
Journal: International journal of hematology
Published: November 26, 2014
HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 08, 2014
Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: February 05, 2014
Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.
Journal: Bioorganic & medicinal chemistry letters
Published: September 12, 2013
Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension.
Journal: Bioorganic & medicinal chemistry letters
Published: April 17, 2013
Prognostic factors in adult acute lymphoblastic leukemia
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: November 09, 2012
A case series of Bacillus cereus septicemia in patients with hematological disease.
Journal: Internal medicine (Tokyo, Japan)
Published: October 06, 2012
Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas.
Journal: Oncology reports
Published: September 17, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026